Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Artif Intell Med. 2013 Jun 2;58(3):155–163. doi: 10.1016/j.artmed.2013.04.008

Table 1.

Performance of confidence methods for colon cancer (62 samples: 22 class 1, 40 class 2)a.

LEVEL N POS ACC SEN SPC PPV NPV
Overall 61.0(0.9) 65.1(1.3) 90.2(1.4) 91.9(1.0) 86.9(3.3) 92.9(1.8) 85.2(2.0)
Method 1
Highest 20.0(2.4) 82.7(4.3) 94.7(2.7) 96.3(3.2) 86.8(16.2) 97.4(3.0) 84.5(13.8)
Intermediate 36.3(3.0) 60.0(3.6) 89.5(2.2) 90.8(4.0) 87.5(4.8) 91.7(2.7) 86.7(4.9)
Lowest 4.8(1.7) 30.3(17.1) 76.9(18.3) 52.3(42.6) 85.1(18.4) 59.4(42.1) 83.3(16.5)
Method 2
Highest 51.5(2.6) 70.9(1.5) 92.0(1.5) 94.1(1.9) 86.4(4.9) 94.5(1.7) 86.0(4.1)
Intermediate 4.9(1.0) 26.2(21.2) 88.5(12.7) 78.9(31.2) 90.7(15.6) 78.9(31.2) 92.8(12.0)
Lowest 4.7(1.8) 38.6(19.3) 74.6(20.8) 57.8(36.9) 81.3(23.4) 70.2(25.5) 79.1(21.3)
a

The first row shows the overall performance of the selective-voting algorithm based on 20 repetitions of 10-fold CV. Column 1 designates the subpopulation confidence, where Method 1 corresponds to ‘clustering training samples according to AM and assigning test samples according to VM’, and Method 2 corresponds to ‘clustering training samples according to AV and assigning test samples according to VV’ (see section 2.2). N (column 2) is the average number of samples in each subpopulation among the total samples that were classified by the selective-voting algorithm across the 20 repetitions, and POS (column 3) indicates the average percentage of positive (class 2) samples among the N samples. The performance measures in columns 4–8 are defined in section 2.4. The numbers in parentheses are standard deviations.